Business First of Louisville -- Ampersand Ventures, a Wellesley, Mass.-based venture capital firm, has joined the management team of MedVenture Technology Corp. to buy out MedVenture’s previous investors.
The deal gives Jeffersonville-based MedVenture the capitalization it needs to grow as an international medical device developer and contract manufacturer, MedVenture CEO Kevin Bramer said in a news release.
Bramer could not immediately be reached for comment.
The company did not disclose who the MedVenture shares were purchased from or how much Ampersand and the MedVenture managers paid for them. They also did not disclose which MedVenture managers acquired shares in the company.
“We are excited about our partnership with Ampersand,” Bramer said in the news release. “We believe that they share our focus on strategic growth, exceptional customer service, quality technology development and advanced manufacturing.”
